| INTRODUCTION
Enriched environment treatment (EET), which combines physical exercise, mental stimulation and social interaction, [1] [2] [3] [4] is a potential intervention for depression. [5] [6] [7] EET induces expression of brain-derived neurotrophic factor (BDNF), [8] [9] [10] [11] [12] [13] a critical neuronal growth factor implicated in the pathophysiology of depression. [14] [15] [16] [17] [18] [19] Decreased BDNF expression has been observed in the hippocampus and prefrontal cortex of depressed humans 20 and stressed animals. [21] [22] [23] In particular, inactivation of promoter IV via epigenetic modification is linked to depression 24, 25 and stress. 23, 26, 27 Promoter IV-driven BDNF deficiency leads to depression-like behavior in mice. 28 We previously found that EET was more effective than treatment with 4 classes of antidepressant drugs in reversing the depression-like behavior caused by the promoter IV-BDNF deficiency in young-adult (YA) mice. 10, 29 While 9 promoters control BDNF gene expression in both humans and rodents, 30, 31 EET induces BDNF expression driven by promoters I, II and III 10, [32] [33] [34] with epigenetic modification at promoters II, IV and VI. 35, 36 Despite the well-established BDNF effects of EET, what remains unclear is its age dependency, particularly for effectiveness against depression. Does EET affect depression differently across ages? This information is important in developing effective strategies for prevention and treatment of depression. We recently examined EET effects across 3 distinctive life stages in mice: early-life development (ED), young-adulthood and old-adulthood. We found that EET effects in increasing exploratory activity and anti-despair behavior were largest and long-lasting when EET was provided during ED, particularly in and the BDNF protein-coding region. 38 KIV mice were generated from 129cX/Sv × 129X1/SvJ ES cells and then crossed to C57BL/6J females for more than 12 generations. Heterozygous mice were bred to produce WT and KIV littermates of the same genetic background.
Offspring from these littermates were used.
EET effects were examined at 3 life stages: ED (0-2 months), YA (2-4 months) and OA (12-14 months); these life stages represent development before reproductive maturity, after sexual maturity and middle-age in mice. 40, 41 Male and female mice were used to examine sex-specific effects.
A cohort of mice was used to assess EET effects on anhedonia The same animals in our previous study 37 were used in this study. Mice were group-housed with standard bedding in a climate-controlled vivarium on a normal 12-hour dark/light cycle with ad libitum access to food and water. All animal experiments were approved by the University of Tennessee Laboratory Animal Care and Use Committee.
| Treatments
Age-and sex-matched mice were randomly assigned to standard condition treatment (SCT) or EET, as described previously. 10, 37 Briefly, SCT consisted of a small 27 × 16 × 12 cm cage containing 2 to 5 mice, group-housed to avoid isolation stress. EET consisted of a larger 44 × 22 × 16 cm cage, containing one plastic running wheel per 5 mice to allow for physical activity, a variety of toys to increase perception and mental exercise, and 5 to 10 company mice with nesting material to increase social interaction. Toys were replaced weekly, and mice in EET cages were given bacon-flavored Rodent Foraging
Crumbles (Bio-Serv, Frenchtown, New Jersey) to encourage exploration in the enriched environment.
The treatment period of 2 months was used to encompass mouse development from birth to reproductive maturity. ED-EET mice were born and raised in an EET cage, then weaned to another EET cage at 3 weeks of age until 2 months of age. YA-EET and OA-EET mice started treatment at 2 or 12 months of age, respectively. After treatment, EET mice were then placed in standard condition (EET-SCT), while SCT mice remained in standard condition (SCT-SCT), for 1 additional month to determine, if any, the persisting effects of EET (see Figure 1A for research design).
| Sucrose preference test
This test was used to assess mouse anhedonia 28, 42 after the initial 2 months of SCT or EET and, again, after 1 month of SCT (at T 1 and T 2 in Figure 1A ). Mice were habituated to 2 water bottles for 4 days and then water-deprived overnight (17:00-9:00 hours). During a 3-hour session (9:00-12:00 hours), mice were housed individually and given access to one bottle of regular water and one bottle of preferable 1% sucrose solution. Liquid consumption was measured by weighing each bottle before and after consumption, and sucrose preference was calculated, as total sucrose water intake/total (sucrose + water) intake. 43 
| RNA Extraction and qRT-PCR by BioMark
Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to measure total BDNF mRNA levels and to identify the involved promoters by detecting each transcript driven by 9 BDNF promoters. Hippocampus and frontal cortex tissues were collected between 14:00 and 17:00 hours from the 4 treatment groups (SCT/EET at T 1 and SCT-SCT/EET-SCT at T 2 , see Figure 1A ) and stored at −80 C until processed. Each sample was homogenized by pipet and QIAshredder (Qiagen, Valencia, California). Total RNA was extracted using an RNeasy Kit with on-column DNase (Qiagen) and quantified using the NanoDrop spectrophotometer (Agilent Technologies, Santa Clara, California). One microgram of total RNA was converted to cDNA (First Strand cDNA Synthesis Kit, Roche Applied Science, Indianapolis, Indiana). qRT-PCR was performed using BioMark, as described previously. [44] [45] [46] 47 Gene expression values were normalized to the average values of gene expression in control mice (eg, respective SCT groups). Information on primers and probes is presented in Table S1 , Supporting Information. Note that all KIV groups showed reduced sucrose preference and that EET reversed it regardless of age and sex, which lasted 1 month after discontinuance with significant increases in KIV ED males and females and YA males. N = 11 to 15 per group (shown at the bar). *P < .05, **P < .01, ***P < .005 sucrose preference (WT vs KIV: P < .05 for each, detailed statistics are presented in Table S2 , Figure 1B ). No age effects were observed in the reduced sucrose preference of KIV mice of either sex (ED, YA and OA: F male(2,28) = 0.3, P > .05, F female(2,28) = 0.4, P > .05, 1-way ANOVA, Figure S1A ), indicating that promoter IV-BDNF deficiency universally caused anhedonia.
| Statistical analysis

| EET effects
Next, we asked whether EET effects on anhedonia are age-dependent. EET across all ages significantly increased sucrose preference of KIV mice for both sexes (KIV, SCT vs EET: P < .05 for each, see Table S2 for statistical details), while normalizing its reduction to the levels of WT mice in SCT (WT-SCT vs KIV-EET: P > .05, Student t test, Figure 1B ). No age-specific effects were observed in the EET effects for either sex (F male(2,84) = 2.1, P > .05, F female(2,83) = 0.04, P > .05, Figure S1B ). EET did not change the sucrose preference in WT mice at any life stage (WT, SCT vs EET: P > .05 at any age, Figure 1B ).
These results indicated that EET reversed anhedonia caused by BDNF deficiency, regardless of age and sex, but did not increase sucrose preference in normal conditions.
| Lasting EET effects
We then investigated whether the EET effects in reversing anhedonia would persist without EET and whether the effects differ across ages.
One month after EET discontinuance, all KIV groups with EET presented similar sucrose preference levels as WT mice (KIV EET-SCT vs WT SCT-SCT: P > .05 at any ages). Significant EET-induced increases were observed only in ED KIV males and females and YA KIV males (KIV SCT-SCT vs EET-SCT: P < .05 for each, Figure 1C ). These results indicated that EET effects in reversing anhedonia persisted, regardless of age and sex, with significant effects when EET was provided in early life.
| Total BDNF mRNA levels across ages
We next examined the age-dependent effects of promoter IV-BDNF deficiency and EET on BDNF gene transcription. Total BDNF mRNA levels were measured by the levels of exon IXc, the common BDNF protein-coding region shared by transcripts driven by all 9 BDNF promoters.
30,31
| Basal levels
Age effects on basal BDNF levels without EET were examined by comparing SCT groups at ED, YA and OA. Only WT frontal cortex showed age-dependent decline of basal BDNF levels (WT-SCT, OA vs ED or YA: P < .05, Figure 2A ). KIV mice presented significant reductions in total BDNF mRNA levels in both frontal cortex and hippocampus, regardless of age, when compared with WT mice (WT-SCT vs KIV-SCT: P < .001 for each, Figure 2A ).
| EET effects
In the hippocampus, EET significantly increased total BDNF mRNA levels in all age groups for both genotypes (SCT vs EET: at least P < .05; Figure 2B , left). No significant effects of aging and genotype were observed (P > .05, Tables S2 and S3 ). By contrast, in the frontal cortex, significant effects of age and genotype were observed (F age(2,42) = 4.4, P < .05; F genotype(1,42) = 9.2, P < .01), where EET increased total BDNF mRNA levels only in ED KIV mice and OA WT mice (SCT vs EET: P < .005 for each; Figure 2B , right).
| Lasting EET effects
One month after EET discontinuance, treatment × age interactions were observed for both regions (F hippocampus(2,38) = 6.28, P < .01; Total BDNF mRNA levels (the protein-coding exon IXc) in the hippocampus (left) and frontal cortex (right) at ED, YA, and OA. A, Basal levels in standard conditions. Asterisks on the columns show significant differences between genotypes. N = 14 to 16 per group. B, EET effects shown by fold changes of BDNF levels in mice with EET divided by those with SCT. Asterisks on the columns show significant BDNF induction in EET group compared with SCT group. N = 6-8 per group. C, Lasting effects of EET shown by fold changes of BDNF levels in mice with EET and consequent SCT (EET-SCT) divided by levels in SCT mice (SCT-SCT). N = 6-8 per group. *P < .05; **P < .01; ***P < .005
| EET activation of BDNF promoters across ages
We further examined which promoters contributed to EET-induced BDNF transcription. We examined activity of 9 promoters by measuring mRNA levels of the immediately downstream BDNF exons IIXa. 30, 31 3.3.1 | Basal levels of each BDNF exon WT mice showed age-dependent decline of all BDNF exons except for exon V in the hippocampus, (ED vs OA: at least P < .05 for each; Figure S2 , left). WT mice showed age-dependent decline of only exon I in the frontal cortex (OA vs ED: P < .005; Figure S2 , right), which likely accounted for the age-dependent decline of total BDNF mRNA levels (exon IXc; Figure 2 , right). KIV mice showed age-dependent decline of only exons I in both hippocampus and frontal cortex (YA vs OA: at least P < .05; Figure S2 ). KIV mice, when compared with WT mice, showed reduced levels of almost all exons in both regions in all age groups (except VI in YA groups) (WT vs KIV: P < .05; Figure S2 ), which reproduced previous findings in YA KIV mice. 48, 49 Promoter IV-BDNF deficiency may reduce other promoter activity, regardless of age.
| EET effects across ages
In the hippocampus, both WT and KIV mice showed significant EET effects for almost all exons (at least P < .05, except for exon V in KIV mice, Table S2 ). EET significantly increased levels of exons IIa, IIb, IIc, III, VI, VIIa, VIII and IXa (EET vs SCT: at least P < .05) without any age or genotype effects (among ED, YA and OA or WT vs KIV: P > .05; where significant age effects were observed (ED vs YA/OA: at least P < .05, Figure 4) . These results indicated sustained activity of several promoters after EET, only when EET was provided during early life, specifically in the promoter IV-deficient condition.
| DISCUSSION
Results of the present study showed 4 major findings: 
| Anhedonia
Previous studies have shown that BDNF deficiency reduces sucrose preference in YA KIV males 10, 28 and CaMKII promoter-controlled BDNF knockout females. 50 This study expanded these findings across ages for both males and females. KIV mice also show reduced exploratory activity and increased stress-induced despair at any age and sex. 37 Together, our results suggest that promoter IV-BDNF deficiency commonly causes depression-like behavior, regardless of age and sex.
Our findings of no sex difference in KIV (promoter IV-knockin) mice contrast with sex difference in depression-related behavior in BDNF-coding-region knockout mice (+/− and conditional). 50, 51 These knockouts retain promoter IV-driven BDNF expression: half in BDNF +/− mice and intact in regions/cells unaffected by the exogenous promoters (e.g. CaMKII). The BDNF loss in the knockouts may be insufficient to cause anhedonia, but is prone to do so when promoter IVdriven BDNF levels are further reduced under stress 21, 23 and females may be more susceptible to stress. 52 BDNF deficiency in the endogenous-promoter IV-controlled regions/cells (e.g. hippocampal
CA1 and prefrontal cortex pyramidal cells) is likely critical to cause depression-related behavior [detailed discussion in Reference 28]).
In humans, depression affects anyone, although the prevalence of depression is sex-and age-dependent: depression is more common among females (5.1%) than males (3.6%), particularly around 60 years of age and in puberty-related teenage children. 53 Chronic mild stress has been shown to decrease sucrose preference in adult, but not juvenile, rats. 54 It is possible that the susceptibility to chronic stress, which decreases BDNF expression, may be age-and sex-dependent, whereas BDNF deficiency commonly causes depressive behavior. No age-related changes in sucrose preference were observed in normal WT mice in this study, similar to a previous finding by Tordoff et al, 55 while age-dependent declines have been reported in >17 month-old rodents. 56, 57 In this study, EET reversed reduced sucrose preference caused by promoter IV-BDNF deficiency, regardless of age. This universal effect of EET in normalizing anhedonia was in contrast to our previous findings of an age-dependent effect of EET in increasing exploratory Our results showed no sex difference in the EET effects on sucrose preference at any life stage. These results were similar to no sex difference in EET effects on exploratory activity and stressinduced despair. 37, 51 These findings together suggest that EET is equally effective in both sexes for reducing depressive behavior caused by BDNF deficiency.
Interestingly, the significant increases in sucrose preference persisted only with early-life EET, similar to the lasting increases in exploratory activity and stress resilience with early-life EET. 37 These 
| BDNF gene induction by EET across ages
Previously, we had shown that EET-induced levels of BDNF protein were larger in ED than in adult groups. 37 We hypothesized that this age dependency might be due to more flexible transcriptional regulations earlier in life, which can last longer such as by epigenetic changes. Thus, this study further clarified EET effects on BDNF gene transcription across ages. Our results showed that EET induction of total BDNF mRNA was observed regardless of age and genotype in the hippocampus, but only in ED KIV mice and OA WT mice in the frontal cortex. These results suggest that the age dependency of EET effects in increasing BDNF transcription differs among the brain regions. Early life is likely critical for EET to induce BDNF transcription in the frontal cortex particularly in promoter IV-BDNF deficiency.
BDNF induction in the OA WT frontal cortex was likely due to the relatively reduced basal levels of BDNF in OA WT mice, suggesting a beneficial effect of EET on normal aging.
Our current results regarding BDNF mRNA levels contained a few discrepancies when compared with our previous results of BDNF protein levels. 37 First, EET induction of BDNF protein in the hippocampus was more prominent at early life than at old-adulthood, 37 but that of BDNF mRNA was relatively similar across ages in this study.
One possibility is that EET also increases translation of the BDNF transcripts and/or decreases degradation of BDNF protein, and that the post-transcriptional effects in the hippocampus may be larger during ED than at old-adulthood. Second, basal levels of BDNF mRNA declined age-dependently in the frontal cortex of WT mice, but those of BDNF protein were similar across ages in our previous study. 37 The basal levels of BDNF protein may be protected by homeostatic posttranslational regulation, such as reduced degradation of BDNF protein at aged stages.
| Anhedonia related to hippocampal BDNF levels
EET effects in reversing reduced sucrose preference and inducing hippocampal BDNF mRNA were similarly observed across age, whereas EET effects in inducing frontal cortex BDNF mRNA were limited only at ED in KIV mice. These results suggest that BDNF induction by EET in the hippocampus, rather than the frontal cortex, is critical for reducing anhedonia. Taliaz et al 58 have shown evidence of hippocampal BDNF directly controlling anhedonia: hippocampus-specific BDNF knockdown reduced sucrose preference while its over-expression normalized a reduction of sucrose preference caused by chronic mild stress in rats. Our result showed increases in hippocampal BDNF but no change in sucrose preference in WT mice, which was also consistent with their findings in normal adult rats. 59 
| BDNF promoter activity
This study showed that almost all promoters (I-IX), rather than a limited number of promoters, contributed to the BDNF transcription induced by EET in both hippocampus and frontal cortex. These results correspond with the previous studies showing that EET drives multiple BDNF promoters in the hippocampus of YA animals (I, II, III, IV and V), 10, 33, 34, 60 and expanded similar findings in earlier (ED) and later (OA) in life and in the frontal cortex. Our novel findings were the age-dependent responses of promoters I and IV to EET in the hippocampus and almost all promoters in the frontal cortex. It should be noted that promoters I and IV are activity-dependent, that is, activated by calcium influx in depolarized neurons. [61] [62] [63] While our present study measured static levels of BDNF transcripts without neuronal activity (e.g. by learning), EET may also affect neuronal activity-induced BDNF transcription driven by these promoters at specific life stages.
The present study showed that exon I was more effectively induced by EET in OA groups rather than in ED groups in both hippocampus and frontal cortex of WT mice. This result is in accordance with the recent finding by Neidl et al 64 that EET in 18-24 month old normal rats significantly increases BDNF transcription by promoter I but not by promoter IV or VI. Promoter I activation by EET involves increases in histone 3 acetylation on a proximal nuclear factor κB site in the promoter region. 64 Promoter I can also be activated by showed no promoter I activation (exon I) by EET in OA KIV mice. This result suggests that the system of nuclear factor κB site acetylation or demethylation at H3K9 to activate promoter I may be defective or interacted by promoter IV-BDNF deficiency.
The results of age-dependency on EET activation of specific BDNF promoters also suggest that EET may affect different types of behavior at different ages because of subregion-specific controls of BDNF promoters. Promoter I is more active in the dentate gyrus, while promoter IV is more active in the CA1 region of the hippocampus. 18, 66, 67 Therefore, EET activation of promoter I at OA or promoter IV at ED may increase BDNF levels in the dentate gyrus or the CA1, respectively, which can lead to different types of neural effects (e.g.
neurogenesis, network activity) and behavior (e.g. pattern separation, learning and memory). 11, [68] [69] [70] [71] In the frontal cortex, EET-induced activity of almost all promoters was age-dependent, observed mostly in ED KIV mice. These results agree with the largest induction of total BDNF mRNA levels and BDNF protein levels in ED KIV mice in this study and in our previous study. 37 Defective promoter IV-driven BDNF transcription has been observed in the frontal cortex under early-life maltreatment. 21 Our findings suggest that EET implemented at early life, but not at the later time, is critical to compensate for promoter IV-BDNF deficiency by activating alternative promoters in the frontal cortex.
Furthermore, our results showed that EET effects on promoterspecific BDNF induction in both the hippocampus and frontal cortex were mostly sustained only at ED in promoter IV-BDNF deficiency.
This result highlights early life as a critical period to induce lasting BDNF transcription possibly due to the homeostatic compensational effects in promoter IV defect, while the EET effects may already be maximal in the normal condition (ceiling effects).
4.5 | Why is EET at ED more effective than EET at later life in inducing lasting BDNF transcription in BDNF deficiency?
The exact reason is unknown, but one possibility is due to epigenetic programming (e.g. DNA and histone modifications) which is more drastic, flexible 72 and long-lasting [72] [73] [74] [75] during ED than in adulthood.
Indeed, a dynamic demethylation at BDNF promoters I, II, IV and VI has been reported from embryonic pallium to the neonate hippocampus at postnatal day 7. 76 The dynamic epigenetic programming may change BDNF transcriptional regulation and allow animals to adapt to the exposed environment by changing neuronal plasticity. 77 Additionally, early-life EET involves mother-pup/infant social enrichment. The importance of mother-infant relations for lasting physiological changes has been proposed for over 60 years in both human 78, 79 and animal models. 74, 80, 81 Interestingly, mother-pup social enrichment is increased by their brief (~15 minutes) separation, which can occur as mothers engage in EET (e.g. running). The brief separation increases the licking and grooming of pups upon reunion, 82 and gentle touching increases the resistance of pups to physiological stress later in adulthood. 
| Early-life EET as intervention for anhedonia and BDNF deficiency
Our data showed larger, long-lasting effects of early-life EET on anhedonia and BDNF induction in KIV mice, suggesting that EET was more effective in reversing the defects in behavior and BDNF levels, rather than in increasing these beyond the normal state. In real life, EET may be more effective for people in adverse environments (e.g. isolation and stress), rather than enhancing normal environments.
Our findings also provide an important notion of when to implement EET for its maximal and lasting effects. While promoter IV-BDNF deficiency is implicated in depression, 20, 24, 25 epigenetic inactivation of promoter IV occurs by exposure to toxic environments, such as perinatal methylmercury, 89 early-life maltreatment, 21 chronic social stress 23 and maternal low-protein diet. 90 Defective promoter IVdriven BDNF transcription can transmit across generations via abnormal maternal behavior and depression. 21 To break this vicious cycle of promoter IV defect and mother-infant maltreatment, early-life EET is likely critical and can reduce risk of depression later in life. Earlydetection of BDNF deficiency, such as by measuring promoter IV inactivity and related biomarkers, would aid in initiating earlylife EET.
| Limitation and future directions
The EET in this study combined physical, mental and social activity, so it is unclear which components are responsible for the anti-anhedonic effects and BDNF induction. The EET also covered birth through maturation, so the precise critical period (e.g. gestation, before weaning, childhood or adolescence) for the most effective EET also remains unclear. Future studies can determine a more precise period in early life when EET provides the largest effects. Our hypothesis is that EET is most effective when neurons rapidly proliferate, migrate, and mature and before neurons and synapses start to decrease by apoptosis and pruning. This study only measured static levels of BDNF transcription.
It will be of interest to elucidate how EET affects BDNF transcriptional activity upon stimuli (new environments, learning training, etc.) and how this affects the development of neuronal network connectivity and more broad behavioral phenotypes related to depression (eg, flexible learning, anxiety, susceptibility to stress and drug addiction, etc.).
Although KIV mice have been extensively backcrossed (>12 times) to C57BL/6J, 129Sv genes in the close vicinity of the BDNF gene may remain in KIV mice and might have affected the EET responsivity.
| CONCLUSION
The present study aimed to identify the life period when EET is most 
